권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 대표형(전거형, Authority) | 생물정보 | 이형(異形, Variant) | 소속 | 직위 | 직업 | 활동분야 | 주기 | 서지 | |
|---|---|---|---|---|---|---|---|---|---|
| 연구/단체명을 입력해주세요. | |||||||||
|
|
|
|
|
|
* 주제를 선택하시면 검색 상세로 이동합니다.
목차 1
시신경염의 병태생리, 임상양상 그리고 진단 = Optic neuritis : pathophysiology, clinical features, and diagnosis / 이연희 1
[요약] 1
서론 1
시신경염의 임상양상과 증상, 증후 2
시신경염의 각종 검사 소견 3
1. 시기능 검사 소견 3
2. 자기공명영상 소견 3
3. 혈청검사와 뇌척수액검사 소견 4
시신경염의 치료 4
개별 질환 5
1. 다발경화증 연관 시신경염 5
2. 시신경척수염스펙트럼장애 연관 시신경염 5
3. 수초희소돌기아교세포당단백질 항체 연관 시신경염 6
4. 전신면역질환과 연관된 시신경염 6
5. 육아종성 질환에 의한 시신경염 7
6. 감염성 시신경병증 7
7. 신경망막염 8
결론 8
References 9
Peer Reviewers' Commentary 10
| 기사명 | 저자명 | 페이지 | 원문 | 목차 |
|---|---|---|---|---|
| 의정갈등과 필수의료, 지방의료 불균형 해결을 위한 제의 = Proposals for resolving medical conflicts and addressing essential and regional healthcare disparities in Korea | 임현택, 박일현 | p. 494-499 |
|
보기 |
| 나이 관련 황반변성 = Age-related macular degeneration | 지동현 | p. 500-505 |
|
보기 |
| 시신경염의 병태생리, 임상양상 그리고 진단 = Optic neuritis : pathophysiology, clinical features, and diagnosis | 이연희 | p. 507-516 |
|
보기 |
| 생체표지자로 진단되는 급성 시신경염 = Biomarker defined acute optic neuritis | 이행진 | p. 517-523 |
|
보기 |
| 소아 시신경염 = Pediatric optic neuritis | 설동헌, 한진우 | p. 524-530 |
|
보기 |
| 이식형 보청기의 최신 지견 = Up-to-date knowledge of implantable hearing aids | 이전미 | p. 531-538 |
|
보기 |
| 국민건강보험공단 조사 권한의 문제점과 개선방안 = Improvement methods for addressing issues in National Health Insurance Corporation’s investigation authority | 임지연, 김진숙, 문석균 | p. 541-547 |
|
보기 |
| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | Beck RW, Cleary PA, Anderson MM, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992;326:581-588. | 미소장 |
| 2 | Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis:international recommendations on diagnosis and antibody testing. J Neuroinflammation 2018;15:134. | 미소장 |
| 3 | Jurynczyk M, Messina S, Woodhall MR, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 2017;140:3128-3138. | 미소장 |
| 4 | Ramanathan S, Prelog K, Barnes EH, et al. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler 2016;22:470-482. | 미소장 |
| 5 | Merle H, Olindo S, Jeannin S, et al. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. Arch Ophthalmol 2012;130:858-862. | 미소장 |
| 6 | Kang TS, Lee W, Lee YH. Optic neuritis of Korean adult. J Korean Ophthalmol Soc 2018;59:81-86. | 미소장 |
| 7 | Keltner JL, Johnson CA, Spurr JO, Beck RW. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 1993;111:231-234. | 미소장 |
| 8 | Merle H, Olindo S, Jeannin S, et al. Visual field characteristics in neuromyelitis optica in absence of and after one episode of optic neuritis. Clin Ophthalmol 2013;7:1145-1153. | 미소장 |
| 9 | Kupersmith MJ, Mandel G, Anderson S, Meltzer DE, Kardon R. Baseline, one and three month changes in the peripapillary retinal nerve fiber layer in acute optic neuritis: relation to baseline vision and MRI. J Neurol Sci 2011;308:117-123. | 미소장 |
| 10 | Kupersmith MJ, Alban T, Zeiffer B, Lefton D. Contrastenhanced MRI in acute optic neuritis: relationship to visual performance. Brain 2002;125:812-822. | 미소장 |
| 11 | Kapoor R, Miller DH, Jones SJ, et al. Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology 1998;50:230-237. | 미소장 |
| 12 | Akaishi T, Sato DK, Nakashima I, et al. MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry 2016;87:446-448. | 미소장 |
| 13 | Chen JJ, Flanagan EP, Jitprapaikulsan J, et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis:clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol 2018;195:8-15. | 미소장 |
| 14 | Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006;63:964-968. | 미소장 |
| 15 | Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibodypositive NMO spectrum disorders. Neurology 2014;82:474-481. | 미소장 |
| 16 | Flanagan EP, Hinson SR, Lennon VA, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol 2017;81:298-309. | 미소장 |
| 17 | Majed M, Fryer JP, McKeon A, Lennon VA, Pittock SJ. Clinical utility of testing AQP4-IgG in CSF: guidance for physicians. Neurol Neuroimmunol Neuroinflamm 2016;3:e231. | 미소장 |
| 18 | Morrow SA, Fraser JA, Day C, et al. Effect of treating acute optic neuritis with bioequivalent oral vs intravenous corticosteroids: a randomized clinical trial. JAMA Neurol 2018;75:690-696. | 미소장 |
| 19 | Kaufman DI, Trobe JD, Eggenberger ER, Whitaker JN. Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Am J Ophthalmol 2000;130:541. | 미소장 |
| 20 | Kidd DP, Burton BJ, Graham EM, Plant GT. Optic neuropathy associated with systemic sarcoidosis. Neurol Neuroimmunol Neuroinflamm 2016;3:e270. | 미소장 |
| 21 | Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol 2014;261:17-26. | 미소장 |
| 22 | Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med 1993;329:1764-1769. | 미소장 |
| 23 | Goodin DS. Perils and pitfalls in the interpretation of clinical trials: a reflection on the recent experience in multiple sclerosis. Neuroepidemiology 1999;18:53-63. | 미소장 |
| 24 | Zivadinov R, Rudick RA, De Masi R, et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001;57:1239-1247. | 미소장 |
| 25 | Deschamps R, Gueguen A, Parquet N, et al. Plasma exchange response in 34 patients with severe optic neuritis. J Neurol 2016;263:883-887. | 미소장 |
| 26 | Bonnan M, Valentino R, Debeugny S, et al. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders. J Neurol Neurosurg Psychiatry 2018;89:346-351. | 미소장 |
| 27 | Aungsumart S, Apiwattanakul M. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: case series and review of the literature. Mult Scler Relat Disord 2017;13:93-97. | 미소장 |
| 28 | Gabilondo I, Martínez-Lapiscina EH, Fraga-Pumar E, et al. Dynamics of retinal injury after acute optic neuritis. Ann Neurol 2015;77:517-528. | 미소장 |
| 29 | Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177-189. | 미소장 |
| 30 | Kleiter I, Gahlen A, Borisow N, et al. Neuromyelitis optica:evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol 2016;79:206-216. | 미소장 |
| 31 | Naismith RT, Tutlam NT, Xu J, et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 2009;72:1077-1082. | 미소장 |
| 32 | Kim SH, Kim W, Li XF, Jung IJ, Kim HJ. Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder? Mult Scler 2012;18:1480-1483. | 미소장 |
| 33 | Hacohen Y, Wong YY, Lechner C, et al. Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease. JAMA Neurol 2018;75:478-487. | 미소장 |
| 34 | Massara A, Bonazza S, Castellino G, et al. Central nervous system involvement in Sjögren’s syndrome: unusual, but not unremarkable. Clinical, serological characteristics and outcomes in a large cohort of Italian patients. Rheumatology (Oxford) 2010;49:1540-1549. | 미소장 |
| 35 | Jarius S, Jacobi C, de Seze J, et al. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 2011;17:1067-1073. | 미소장 |
| 36 | Kampylafka EI, Alexopoulos H, Kosmidis ML, et al. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One 2013;8:e55843. | 미소장 |
| 37 | Lin YC, Wang AG, Yen MY. Systemic lupus erythematosusassociated optic neuritis: clinical experience and literature review. Acta Ophthalmol 2009;87:204-210. | 미소장 |
| 38 | Cross SA, Salomao DR, Parisi JE, et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 2003;54:38-50. | 미소장 |
| 39 | Jarius S, Wandinger KP, Borowski K, Stoecker W, Wildemann B. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg 2012;114:331-335. | 미소장 |
| 40 | Koczman JJ, Rouleau J, Gaunt M, Kardon RH, Wall M, Lee AG. Neuro-ophthalmic sarcoidosis: the University of Iowa experience. Semin Ophthalmol 2008;23:157-168. | 미소장 |
| 41 | Smith GT, Goldmeier D, Migdal C. Neurosyphilis with optic neuritis: an update. Postgrad Med J 2006;82:36-39. | 미소장 |
| 42 | Kahloun R, Abroug N, Ksiaa I, et al. Infectious optic neuropathies: a clinical update. Eye Brain 2015;7:59-81. | 미소장 |
| 43 | Davis EJ, Rathinam SR, Okada AA, et al. Clinical spectrum of tuberculous optic neuropathy. J Ophthalmic Inflamm Infect 2012;2:183-189. | 미소장 |
| 44 | Seo CW. Study on the epidemiological features of Lyme disease in Korea between 2011 and 2018. Korean J Clin Lab Sci 2019;51:436-443. | 미소장 |
| 45 | Kwon HY, Im JH, Lee SM, et al. The seroprevalence of Bartonella henselae in healthy adults in Korea. Korean J Intern Med 2017;32:530-535. | 미소장 |
| 46 | Im JH, Baek JH, Lee HJ, et al. First case of Bartonella henselae bacteremia in Korea. Infect Chemother 2013;45:446-450. | 미소장 |
| 47 | Bhatti MT, Lee MS. Should patients with bartonella neuroretinitis receive treatment? J Neuroophthalmol 2014;34:412-416. | 미소장 |
*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: 정기간행물실(524호) / 서가번호: 국내03
2021년 이전 정기간행물은 온라인 신청(원문 구축 자료는 원문 이용)
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.